Skip to main content
Erschienen in: Archives of Dermatological Research 9/2016

20.09.2016 | Concise Communication

IL-4 and human skin mast cells revisited: reinforcement of a pro-allergic phenotype upon prolonged exposure

verfasst von: Magda Babina, Sven Guhl, Metin Artuc, Torsten Zuberbier

Erschienen in: Archives of Dermatological Research | Ausgabe 9/2016

Einloggen, um Zugang zu erhalten

Abstract

Mast cells (MCs), unique cellular elements of the body, are commonly associated with IgE-mediated reactions and manifestations of Th2-type immunity. A key characteristic of the lineage is its heterogeneity, with subsets displaying significant variation depending on maturation stage, species, tissue, microenvironment and other. Heterogeneity also affects MC responses to extracellular cues. Indeed, IL-4, the signature cytokine of Th2-immunity, can affect MCs in opposing ways ranging from the induction of apoptosis to positive regulation of lineage characteristics. It is unknown, however, whether IL-4 alters the phenotype of terminally differentiated human cutaneous MCs. Using our well-established technique for homogeneous purification of human skin MCs, we now report that prolonged contact with IL-4 not only increases MC expansion, but also phenotypically and functionally re-shapes the cells. FcεRI cell surface expression, FcεRIα-specific mRNA and FcεRI-mediated histamine release are all augmented by IL-4, while histamine release elicited by the non-immunological stimulus, substance P, remains unaffected. IL-4’s potential to mold MCs is broad and similarly detectable across donors. Intriguingly, IL-4 impacts granule-associated mediators, especially histamine whose synthesis is boosted in the presence of IL-4. To our knowledge, an increase in histamine production by IL-4 has not been described yet for any type of MCs, but may well contribute to its pro-allergic effect given the significance of this biogenic amine to allergic symptoms. Collectively, IL-4 alters human skin MCs after long-term exposure mimicking chronic disorders by strengthening MC numbers and intensifying processes associated with allergic inflammation.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Anthony RM, Rutitzky LI, Urban JF Jr, Stadecker MJ, Gause WC (2007) Protective immune mechanisms in helminth infection. Nat Rev Immunol 7(12):975–987PubMedPubMedCentralCrossRef Anthony RM, Rutitzky LI, Urban JF Jr, Stadecker MJ, Gause WC (2007) Protective immune mechanisms in helminth infection. Nat Rev Immunol 7(12):975–987PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Babina M, Guhl S, Stärke A, Kirchhof L, Zuberbier T, Henz BM (2004) Comparative cytokine profile of human skin mast cells from two compartments—strong resemblance with monocytes at baseline but induction of IL-5 by IL-4 priming. J Leukoc Biol 75(2):244–252PubMedCrossRef Babina M, Guhl S, Stärke A, Kirchhof L, Zuberbier T, Henz BM (2004) Comparative cytokine profile of human skin mast cells from two compartments—strong resemblance with monocytes at baseline but induction of IL-5 by IL-4 priming. J Leukoc Biol 75(2):244–252PubMedCrossRef
5.
Zurück zum Zitat Bischoff SC, Sellge G, Lorentz A, Sebald W, Raab R, Manns MP (1999) IL-4 enhances proliferation and mediator release in mature human mast cells. Proc Natl Acad Sci USA 96(14):8080–8085PubMedPubMedCentralCrossRef Bischoff SC, Sellge G, Lorentz A, Sebald W, Raab R, Manns MP (1999) IL-4 enhances proliferation and mediator release in mature human mast cells. Proc Natl Acad Sci USA 96(14):8080–8085PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Brown JM, Wilson TM, Metcalfe DD (2008) The mast cell and allergic diseases: role in pathogenesis and implications for therapy. Clin Exp Allergy 38(1):4–18PubMed Brown JM, Wilson TM, Metcalfe DD (2008) The mast cell and allergic diseases: role in pathogenesis and implications for therapy. Clin Exp Allergy 38(1):4–18PubMed
7.
Zurück zum Zitat FANTOM Consortium and the RIKEN PMI and CLST (DGT), Forrest AR, Kawaji H, Rehli M, Baillie JK, de Hoon MJ, Haberle V, Lassmann T, Kulakovskiy IV, Lizio M, Itoh M et al (2014) A promoter-level mammalian expression atlas. Nature 507(7493):462–470. doi:10.1038/nature13182 FANTOM Consortium and the RIKEN PMI and CLST (DGT), Forrest AR, Kawaji H, Rehli M, Baillie JK, de Hoon MJ, Haberle V, Lassmann T, Kulakovskiy IV, Lizio M, Itoh M et al (2014) A promoter-level mammalian expression atlas. Nature 507(7493):462–470. doi:10.​1038/​nature13182
10.
Zurück zum Zitat Guhl S, Artuc M, Neou A, Babina M, Zuberbier T (2011) Long-term cultured human skin mast cells are suitable for pharmacological studies of anti-allergic drugs due to high responsiveness to FcεRI cross-linking. Biosci Biotechnol Biochem 75(2):382–384PubMedCrossRef Guhl S, Artuc M, Neou A, Babina M, Zuberbier T (2011) Long-term cultured human skin mast cells are suitable for pharmacological studies of anti-allergic drugs due to high responsiveness to FcεRI cross-linking. Biosci Biotechnol Biochem 75(2):382–384PubMedCrossRef
11.
Zurück zum Zitat Guhl S, Lee HH, Babina M, Henz BM, Zuberbier T (2005) Evidence for a restricted rather than generalized stimulatory response of skin-derived human mast cells to substance P. J Neuroimmunol 163(1–2):92–101PubMedCrossRef Guhl S, Lee HH, Babina M, Henz BM, Zuberbier T (2005) Evidence for a restricted rather than generalized stimulatory response of skin-derived human mast cells to substance P. J Neuroimmunol 163(1–2):92–101PubMedCrossRef
12.
Zurück zum Zitat Guhl S, Neou A, Artuc M, Zuberbier T, Babina M (2014) Skin mast cells develop non-synchronized changes in typical lineage characteristics upon culture. Exp Dermatol 23(12):933–935. doi:10.1111/exd.12558 PubMedCrossRef Guhl S, Neou A, Artuc M, Zuberbier T, Babina M (2014) Skin mast cells develop non-synchronized changes in typical lineage characteristics upon culture. Exp Dermatol 23(12):933–935. doi:10.​1111/​exd.​12558 PubMedCrossRef
13.
Zurück zum Zitat Harvima IT, Karkola K, Harvima RJ, Naukkarinen A, Neittaanmäki H, Horsmanheimo M, Fräki JE (1989) Biochemical and histochemical evaluation of tryptase in various human tissues. Arch Dermatol Res 281(4):231–237PubMedCrossRef Harvima IT, Karkola K, Harvima RJ, Naukkarinen A, Neittaanmäki H, Horsmanheimo M, Fräki JE (1989) Biochemical and histochemical evaluation of tryptase in various human tissues. Arch Dermatol Res 281(4):231–237PubMedCrossRef
16.
17.
Zurück zum Zitat Thienemann F, Henz BM, Babina M (2004) Regulation of mast cell characteristics by cytokines: divergent effects of interleukin-4 on immature mast cell lines versus mature human skin mast cells. Arch Dermatol Res 296(3):134–138PubMedCrossRef Thienemann F, Henz BM, Babina M (2004) Regulation of mast cell characteristics by cytokines: divergent effects of interleukin-4 on immature mast cell lines versus mature human skin mast cells. Arch Dermatol Res 296(3):134–138PubMedCrossRef
18.
Zurück zum Zitat Xia HZ, Du Z, Craig S, Klisch G, Noben-Trauth N, Kochan JP, Huff TH, Irani AM, Schwartz LB (1997) Effect of recombinant human IL-4 on tryptase, chymase, and Fc epsilon receptor type I expression in recombinant human stem cell factor-dependent fetal liver-derived human mast cells. J Immunol 159(6):2911–2921PubMed Xia HZ, Du Z, Craig S, Klisch G, Noben-Trauth N, Kochan JP, Huff TH, Irani AM, Schwartz LB (1997) Effect of recombinant human IL-4 on tryptase, chymase, and Fc epsilon receptor type I expression in recombinant human stem cell factor-dependent fetal liver-derived human mast cells. J Immunol 159(6):2911–2921PubMed
Metadaten
Titel
IL-4 and human skin mast cells revisited: reinforcement of a pro-allergic phenotype upon prolonged exposure
verfasst von
Magda Babina
Sven Guhl
Metin Artuc
Torsten Zuberbier
Publikationsdatum
20.09.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Dermatological Research / Ausgabe 9/2016
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-016-1688-x

Weitere Artikel der Ausgabe 9/2016

Archives of Dermatological Research 9/2016 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Riesenzellarteriitis: 15% der Patienten sind von okkulter Form betroffen

16.05.2024 Riesenzellarteriitis Nachrichten

In einer retrospektiven Untersuchung haben Forschende aus Belgien und den Niederlanden die okkulte Form der Riesenzellarteriitis genauer unter die Lupe genommen. In puncto Therapie und Rezidivraten stellten sie keinen sehr großen Unterschied zu Erkrankten mit kranialen Symptomen fest.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Isotretinoin: Risiko für schwere Laboranomalien „marginal erhöht“

08.05.2024 Akne Nachrichten

Die Aknetherapie mit Isotretinoin kann einen Anstieg von Leberenzymen und Blutfetten verursachen. Das Risiko für schwere Störungen ist laut einer Forschungsgruppe der Universität Lübeck aber nur marginal erhöht und auf einen engen Zeitraum konzentriert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.